CAPRIN1 and cancer: Moreover, the latest research has demonstrated that lncRNA CAPRIN1 can inhibit GLS1 translation by driving CAPRIN1-mediated phase segregation in glutamine deficiency, preventing excessive depletion of limited glutamine to maintain cancer survival [142].